PILERCI, SOFIA
 Distribuzione geografica
Continente #
EU - Europa 112
NA - Nord America 105
AS - Asia 57
AF - Africa 1
Totale 275
Nazione #
US - Stati Uniti d'America 105
IT - Italia 37
HK - Hong Kong 21
RU - Federazione Russa 18
IE - Irlanda 17
CN - Cina 16
SE - Svezia 15
SG - Singapore 9
GB - Regno Unito 8
JO - Giordania 6
CH - Svizzera 5
FI - Finlandia 4
DE - Germania 3
FR - Francia 3
IN - India 3
KR - Corea 2
UA - Ucraina 2
SD - Sudan 1
Totale 275
Città #
Chandler 17
Dublin 17
Hong Kong 16
Fairfield 13
Florence 10
Moscow 10
New York 9
Ashburn 8
Shanghai 8
San Diego 6
Bern 5
Kent 5
Singapore 5
Altamura 4
Buffalo 4
Helsinki 4
Lawrence 4
Princeton 4
Boston 3
Los Angeles 3
Prato 3
Siena 3
Woodbridge 3
Beijing 2
Beilngries 2
Houston 2
Kolkata 2
Manchester 2
Medford 2
Montepiano 2
Paris 2
Seoul 2
Southport 2
Wilmington 2
Andover 1
Ann Arbor 1
Boardman 1
Cambridge 1
Carrara 1
Corato 1
Glasgow 1
Lucca 1
Magdeburg 1
Milan 1
Poplar 1
Redwood City 1
Seattle 1
Southwark 1
Torquay 1
Wuhan 1
Totale 202
Nome #
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 87
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib 45
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience 36
Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study 34
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 31
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm 22
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy 17
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network 11
Totale 283
Categoria #
all - tutte 1.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.715


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 6 7 0 1 0 3 1 2 1 1 2
2021/202240 0 9 0 0 0 9 0 5 1 2 5 9
2022/202387 8 15 6 2 2 16 10 6 9 4 3 6
2023/2024107 2 6 6 10 14 14 1 24 3 10 12 5
2024/202525 16 9 0 0 0 0 0 0 0 0 0 0
Totale 283